Vir Biotechnology (VIR) Earnings Date & Reports

A.I. Advisor

published Earnings

VIR is expected to report earnings to rise 3.92% to -105 cents per share on October 31

Vir Biotechnology VIR Stock Earnings Reports

Q3'24

Est.

$-1.06

Q2'24

Missed

by $0.13

Q1'24

Beat

by $0.57

Q4'23

Beat

by $0.22

Q3'23

Missed

by $0.01

The last earnings report on August 01 showed earnings per share of -101 cents, missing the estimate of -88 cents. With 1.63M shares outstanding, the current market capitalization sits at 1.03B.

View a ticker or compare two or three

Compare

VIR

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For VIR
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for VIR (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1800 Owens Street

Phone

+1 415 906-4324

Employees

587

Web

https://www.vir.bio